Stay updated with breaking news from Efflux Mediator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cholesterol Efflux Mediator™VAR 200 is in phase 2a development to reduce renal cholesterol and lipid accumulation that damages the kidneys' filtration system in patients with glomerular...
Cholesterol Efflux Mediator™ VAR 200 is in phase 2a development to reduce renal cholesterol and lipid accumulation that damages the kidneys' filtration system in patients with glomerular diseases, including diabetic
Published data demonstrate that a deficiency in cholesterol transporter ABCA1 increases deposition of cellular cholesterol, contributing to inflammation, cell death , and damage to the kidney’s... | May 15, 2023